全文获取类型
收费全文 | 10993篇 |
免费 | 1059篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 301篇 |
妇产科学 | 274篇 |
基础医学 | 1482篇 |
口腔科学 | 270篇 |
临床医学 | 1245篇 |
内科学 | 1827篇 |
皮肤病学 | 194篇 |
神经病学 | 1214篇 |
特种医学 | 376篇 |
外科学 | 1649篇 |
综合类 | 313篇 |
一般理论 | 7篇 |
预防医学 | 1172篇 |
眼科学 | 257篇 |
药学 | 878篇 |
中国医学 | 16篇 |
肿瘤学 | 479篇 |
出版年
2022年 | 90篇 |
2021年 | 163篇 |
2020年 | 117篇 |
2019年 | 186篇 |
2018年 | 198篇 |
2017年 | 178篇 |
2016年 | 146篇 |
2015年 | 194篇 |
2014年 | 241篇 |
2013年 | 387篇 |
2012年 | 609篇 |
2011年 | 590篇 |
2010年 | 292篇 |
2009年 | 303篇 |
2008年 | 537篇 |
2007年 | 571篇 |
2006年 | 618篇 |
2005年 | 546篇 |
2004年 | 538篇 |
2003年 | 482篇 |
2002年 | 471篇 |
2001年 | 320篇 |
2000年 | 299篇 |
1999年 | 277篇 |
1998年 | 143篇 |
1997年 | 121篇 |
1996年 | 105篇 |
1995年 | 80篇 |
1994年 | 89篇 |
1993年 | 91篇 |
1992年 | 204篇 |
1991年 | 220篇 |
1990年 | 182篇 |
1989年 | 194篇 |
1988年 | 174篇 |
1987年 | 186篇 |
1986年 | 156篇 |
1985年 | 173篇 |
1984年 | 127篇 |
1983年 | 116篇 |
1982年 | 69篇 |
1981年 | 66篇 |
1980年 | 67篇 |
1979年 | 115篇 |
1978年 | 87篇 |
1977年 | 82篇 |
1976年 | 61篇 |
1975年 | 67篇 |
1974年 | 82篇 |
1973年 | 59篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
Immunosuppression of immunoglobulin synthesis seen in patients with multiple myeloma is in part due to immunosuppressive CD5 positive B cells. In a 13 year longitudinal study of an IgA-deficient blood donor who developed multiple myeloma, the presence of immunosuppressive CD5 positive B cells and T cells preceded the diagnosis of overt multiple myeloma and the appearance of immunosuppressive monocytes. These data argue that certain immune defects may be involved in the development of myeloma and are not simply a consequence of overt malignancy. 相似文献
54.
Levin Adeera; Djurdjev Ognjenka; Duncan John; Rosenbaum Debbie; Werb Ron 《Nephrology, dialysis, transplantation》2006,21(2):370-377
Haemoglobin (Hgb) levels are known to be associated with numerousadverse outcomes in both chronic kidney disease (CKD) and non-CKDpatients. This analysis evaluates the association of baseline haemoglobinlevels on survival in CKD patients, who are followed by nephrologists,irrespective of glomerular filtration rate (GFR), prior to initiationof renal replacement therapy (RRT) and erythropoietin hormonereplacement therapy. Analysis of data from the provincial database (PROMIS, PatientRegistration and Outcome Management Information System) in BritishColumbia, Canada, was undertaken. Records used for the analysisincluded all CKD patients at first registration: GFR <60ml/min/1.73 m2, not yet on dialysis, starting from May 1998to October 2002, and who had complete data (defined as age andgender, diabetic status, eGFR and Hgb levels). The primary objective of this study was to determine the associationof Hgb and survival controlling for eGFR at first registrationvalue, age, gender and diabetic status. Multivariate Cox proportionalhazards analysis with time to death as outcome variable wasperformed. The cohort included 3028 patients: the mean age was 65 years,28% were diabetic, and the mean eGFR in the cohort was 21 ml/min/1.73m2. The cohort is representative of the BC CKD and dialysispopulation regarding ethnicity: 64% Caucasian, 32% Asian. Medianfollow-up was 27 months, 1 year survival was 0.92, 2 year survivalwas 0.85. Hgb at initial registration is a statistically independentpredictor of survival (RR = 0.875 for every 10 g/l, 95% CI:0.8350.917, P = 0.0001), after adjusting for age, gender,diabetic status and baseline eGFR. Further analysis, controllingfor RRT, demonstrated a similar association between Hgb andsurvival (RR = 0.853 for every 10 g/l, 95% CI: 0.7990.910,P = 0.0001), after adjusting for above variables. Substantialvariation in Hgb values exists at all GFR levels. These findings underscore the importance of evaluating Hgb atall GFR levels, and the need to study the impact of modificationof Hgb at different GFR levels on survival. 相似文献
55.
In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. 总被引:7,自引:0,他引:7
Chris Heyn John A Ronald Soha S Ramadan Jonatan A Snir Andrea M Barry Lisa T MacKenzie David J Mikulis Diane Palmieri Julie L Bronder Patricia S Steeg Toshiyuki Yoneda Ian C MacDonald Ann F Chambers Brian K Rutt Paula J Foster 《Magnetic resonance in medicine》2006,56(5):1001-1010
Metastasis (the spread of cancer from a primary tumor to secondary organs) is responsible for most cancer deaths. The ability to follow the fate of a population of tumor cells over time in an experimental animal would provide a powerful new way to monitor the metastatic process. Here we describe a magnetic resonance imaging (MRI) technique that permits the tracking of breast cancer cells in a mouse model of brain metastasis at the single-cell level. Cancer cells that were injected into the left ventricle of the mouse heart and then delivered to the brain were detectable on MR images. This allowed the visualization of the initial delivery and distribution of cells, as well as the growth of tumors from a subset of these cells within the whole intact brain volume. The ability to follow the metastatic process from the single-cell stage through metastatic growth, and to quantify and monitor the presence of solitary undivided cells will facilitate progress in understanding the mechanisms of brain metastasis and tumor dormancy, and the development of therapeutics to treat this disease. 相似文献
56.
Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. 总被引:9,自引:0,他引:9
S J Arnott W Duncan G R Kerr P R Walbaum E Cameron W J Jack W J Mackillop 《Radiotherapy and oncology》1992,24(2):108-113
One-hundred-and-seventy-six patients with potentially operable squamous cell carcinoma or adenocarcinoma of the middle or lower thirds of the oesophagus were randomly assigned to preoperative radiotherapy or surgery alone. Patients assigned to the radiotherapy arm received 20 Gy in 10 treatments over 2 weeks, using parallel opposed 4 MV beams. The preoperative radiotherapy was not associated with any significant acute morbidity or any increase in operative complications. The median survival of the overall group of 176 patients was 8 months, and the 5-year survival was 13%. There was no significant difference in the survival of the 90 patients who received preoperative radiotherapy and the 86 who were managed by surgery alone. Proportional hazards analysis identified lymph node involvement, high tumour grade and male sex as significant adverse prognostic features, but the treatment option assigned had no prognostic significance. It was concluded that low dose preoperative radiotherapy offered no advantage over surgery alone. 相似文献
57.
The well established differential pulmonary handling of angiotensins I and II indicates the possibility that vascular receptors for the deca- and octa-peptides do not necessarily involve common sites in the renal vasculature either. Experimental findings involving haemodynamic changes within the kidney in anaesthetised and conscious sheep, with utilization of the angiotensins, and also of noradrenaline, are briefly presented; the implications of the intra-renal water and creatinine transfers are discussed, especially as they concern the possible location of angiotensin receptors in the renal blood vessels. Other aspects of the relationships between the peptides are also taken into account particularly with regard to a postulated angiotensin I [NaCl] dependent peritubular capillary antidiuretic action, angiotensin converting enzyme inhibition, Goldblatt clamp induced hypertension and blood flow through the hind-limbs. 相似文献
58.
59.
A modified end-point enzymatic method for the measurement of ammonia in stool water is presented. A protein precipitation step was included in order to inactivate urease and faecal enzymes, which oxidise NADH. The modified method is reliable, with acceptable precision and accuracy, and is linear up to a concentration of 1.5 mmol/l. 相似文献
60.
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS AND KININ METABOLISM: EVIDENCE THAT ACE INHIBITORS MAY INHIBIT A KININASE OTHER THAN ACE 总被引:1,自引:0,他引:1
Duncan J. Campbell 《Clinical and experimental pharmacology & physiology》1995,22(12):903-911
1. Angiotensin converting enzyme (ACE) converts angiotensin I to angiotensin II, and also metabolizes bradykinin-(1–9) to bradykinin-(1–7) and bradykinin-(1–7) to bradykinin-(1–5). Increases in endogenous kinin levels may contribute to the therapeutic effects of ACE inhibitors. 2. ACE inhibitors increase vascular levels of both bradykinin-(1–9) and its ACE cleavage product bradykinin-(1–7), at doses below the threshold for ACE inhibition, leading to the proposal that ACE inhibitors may also inhibit a non-ACE kininase which cleaves both kinin peptides; this non-ACE kininase may be the major pathway of kinin metabolism in the vasculature and some other tissues. 3. In support of this proposal, ACE inhibitors potentiate bradykinin-(1–9) effects at doses which have little or no effect on ACE activity, as indicated by angiotensin I conversion to angiotensin II. ACE inhibitors also potentiate the actions of ACE-resistant kinin analogues, which may be susceptible to metabolism by a non-ACE kininase. 4. Identification and characterization of the putative non-ACE kininase which is inhibited by ACE inhibitors may reveal novel approaches to the tissue-specific modulation of kinin levels. 相似文献